The Advanced Medical Technology Association (AdvaMed) and Biocom, the association representing the California life science industry, have announced a joint partnership to collaboratively produce The Digital MedTech Conference 2020. In combining Biocom’s DeviceFest and Digital Health Conference with AdvaMed’s Digital MedTech Conference, the single event will highlight the evolving digital medtech landscape and explore trends impacting the industry, all while bringing together key leaders from California and beyond.
Founder and CEO, MG Therapies, Inc.
David McMahon, MBA, MS is the Founder and CEO of MG Therapies Inc., a revenue stage company in the ophthalmology space focused on treating Dry Eye Disease. Mr. McMahon has over 20 years of medical device experience developing and commercializing medical devices in Fortune 10 corporations as well as a founder of multiple medical product start-ups. Mr McMahon’s corporate experience includes executive positions with: Applied Medical, Alaris Medical, Cardinal Health and Luminous Medical. He has been directly involved in commercializing 10 FDA Class II devices and numerous Class I devices in his career.